Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Fuji
Cerilliant
Novartis
Medtronic
Queensland Health
Johnson and Johnson
US Army
McKesson
Deloitte

Generated: October 19, 2017

Patent: ► Subscribe

Summary for Patent: ► Subscribe

Title:Diagnosis and treatment of brain tumor
Abstract: Cellular targets on cancer cells have been identified that can be used with targeted molecular imaging to detect the cancer cells in vivo. Non-invasive methods for detecting cancer cells, such as metastasized cancer cells, are therefore provided. Also provided are compositions and kits for use in the disclosed methods.
Inventor(s): Ruoslahti; Erkki (Buellton, CA), Laakkonen; Pirjo (Helsinki, FI)
Assignee: Sanford-Burnham Medical Research Institute (La Jolla, CA)
Application Number:14/396,414
Patent Claim Types:
see list of patent claims
Use; Composition;

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Inventors Patent Expiration Status Orphan Source
Genentech
HERCEPTIN
trastuzumab
VIAL; INTRAVENOUS1037920011998-09-25► Subscribe Sanford-Burnham Medical Research Institute (La Jolla, CA) Ruoslahti; Erkki (Buellton, CA), Laakkonen; Pirjo (Helsinki, FI) ► SubscribeRXOrphansearch
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Summary for Patent: ► Subscribe

PCT Information
PCT FiledApril 25, 2013PCT Application Number:PCT/US2013/038219
PCT Publication Date:October 31, 2013PCT Publication Number: WO2013/163431

International Patent Family for Patent: ► Subscribe

Country Document Number Publication Date
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Medtronic
Healthtrust
QuintilesIMS
UBS
Deloitte
Federal Trade Commission
Harvard Business School
Boehringer Ingelheim
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot